Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2025-09-16 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
권리락 (유상증자)
Share Issue/Capital Change Classification · 1% confidence The document is a short announcement regarding a 'rights offering' (유상증자) and the resulting 'ex-rights' (권리락) date for Corestemchemone. It is a brief notice of a capital change event rather than a full report, fitting the criteria for a share-related announcement.
2025-09-16 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등거래계획보고서) filed by an executive of Corestemchemone Co., Ltd. This is a regulatory filing required by the Financial Services Commission and the Korea Exchange in South Korea when insiders plan to trade their company's securities. Since it does not fit into specific categories like 'Director's Dealing' (which is for completed trades) or 'Major Shareholding Notification' (which is for threshold crossings), and it is a formal regulatory disclosure, it falls under the 'Regulatory Filings' category.
2025-09-12 Korean
[기재정정]증권신고서(지분증권) (2025.10)
Capital/Financing Update Classification · 1% confidence The document is explicitly titled '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment). It details amendments to a previously filed registration statement, including updates to risk factors and business descriptions. In the context of financial filings, a Securities Registration Statement is a primary regulatory document for capital raising or equity offerings, which falls under the 'Regulatory Filings' category as it does not fit into the specific categories like 10-K, ER, or IP.
2025-09-08 Korean
[기재정정]증권신고서(지분증권) (2025.10)
Capital/Financing Update Classification · 1% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by '코아스템켐온 주식회사'. This is a formal regulatory filing submitted to the financial authorities (such as the Financial Supervisory Service in Korea) to update information regarding a securities offering, specifically detailing risks related to clinical trials and regulatory approval processes. It is not a report publication announcement, but rather the primary regulatory document itself, which falls under the 'Regulatory Filings' category as it is a formal legal filing for securities registration.
2025-09-01 Korean
주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed with the Financial Supervisory Service/Korea Exchange. It details the issuance of new shares, pricing methods, allocation ratios, and subscription schedules. This falls under the category of capital structure changes and financing activities, which is classified as 'Capital/Financing Update' (CAP).
2025-08-18 Korean
증권신고서(지분증권) (2025.10)
Share Issue/Capital Change Classification · 1% confidence The document is a '증권신고서' (Securities Registration Statement) filed by Corestemchemon Co., Ltd. with the Financial Services Commission (FSC) of South Korea. It details a capital raise (rights offering/public offering) of 20,000,000 shares. In the context of Korean financial filings (DART system), a '증권신고서' is a formal regulatory filing required for public offerings of securities. While it contains extensive risk factors and management information, its primary purpose is the registration of securities for issuance, which falls under the 'Share Issue/Capital Change' category.
2025-08-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.